The Purdue College of Engineering and Indiana University School of Medicine have leveraged their respective engineering and medical infrastructures to rapidly create one of the most productive translational research enterprises. Through an array of company partners in the medical device, biotechnology, and pharmaceutical fields, licenses of clinical technologies have generated over $20 million in royalties from products that have directly helped more than two million patients worldwide. In addition, the strong entrepreneurial spirit of faculty members has resulted in the launch of more than two dozen life science startup companies with over $75 million in venture capital raised and more than 50 patents licensed to major company partners.
Indiana University School of Medicine's comprehensive statewide medical training and healthcare programs provide unmatched resources for translational research and clinical study. With major emphases in such areas as precision medicine and healthcare analytics fueling over $350 million in annual research grants and contracts, noteworthy extramurally-funded partnerships with Purdue such as the NIH-supported Indiana Clinical and Translational Science Institute have emerged to provide key resources that facilitate inter-campus collaborations and serve as a foundation for expansion into new collaborative areas of investigation.
Learn more about the Engineering-Medicine Partnership Translational Research Enterprise: